| Adherence to asthma management guidelines by middle-aged adults with current asthma. | |
| | |
MedLine Citation:
|
PMID: 19703827 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
BACKGROUND: With the increasing burden of asthma worldwide, much effort has been given to developing and updating management guidelines. Using data from the Tasmanian Longitudinal Health Study (TAHS), the adequacy of asthma management for middle-aged adults with asthma was investigated. METHODS: Information about spirometry, medication history and current asthma status was collected by the most recent TAHS when participants were in their mid 40s. Only those who reported ever having asthma were eligible for analysis. RESULTS: Of the 702 participants who reported ever having asthma, 50% had current asthma (n = 351) of whom 71% were categorised as having persistent asthma (n = 98 mild, n = 92 moderate, n = 58 severe). The majority (85.2%) of participants with current asthma had used some form of asthma medication in the past 12 months, but the proportion of the use of minimally adequate preventer medication was low (26%). Post-bronchodilator airflow obstruction increased progressively from mild to severe persistent asthma for those inadequately managed, but not for those on adequate therapy. CONCLUSION: Appropriate use of asthma medication by this middle-aged group of adults with current asthma was inadequate, especially for those with adult-onset moderate or severe persistent disease and without a family history of asthma. These results suggest that proper use of preventer medication could protect against the progressive decline in lung function associated with increasing severity. This has implications not just for poor quality of life, but also for the development of fixed airflow obstruction. |
| | |
Authors:
|
R K Kandane-Rathnayake; M C Matheson; J A Simpson; M L K Tang; D P Johns; D M??sz??ros; R Wood-Baker; I Feather; S Morrison; M A Jenkins; G G Giles; J Hopper; M J Abramson; S C Dharmage; E H Walters |
Related Documents
:
|
16039107 - Comparative improvement of asthma symptoms and expiratory flows after corticosteroid tr... 15612337 - Benefit plan design and prescription drug utilization among asthmatics: do patient copa... 9368977 - Inhaled medications and bronchodilator usage in the horse. 14640927 - Aprepitant--a novel nk1-receptor antagonist. 2782297 - Multiple homicides. 2916917 - Viscoelastic shoe insoles: their use in aerobic dancing. |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't Date: 2009-08-23 |
Journal Detail:
|
Title: Thorax Volume: 64 ISSN: 1468-3296 ISO Abbreviation: Thorax Publication Date: 2009 Dec |
Date Detail:
|
Created Date: 2009-12-02 Completed Date: 2010-01-08 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 0417353 Medline TA: Thorax Country: England |
Other Details:
|
Languages: eng Pagination: 1025-31 Citation Subset: IM |
Affiliation:
|
Centre for Molecular, Environmental, Genetic and Analytic Epidemiology, University of Melbourne, Melbourne, Australia. r.kandane@pgrad.unimelb.edu.au |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adult Anti-Asthmatic Agents / administration & dosage* Asthma / drug therapy*, physiopathology, prevention & control Drug Utilization / statistics & numerical data Epidemiologic Methods Female Forced Expiratory Volume Glucocorticoids / administration & dosage Guideline Adherence / statistics & numerical data Humans Male Patient Compliance* Practice Guidelines as Topic* Self Administration / standards Tasmania Vital Capacity |
| Chemical | |
Reg. No./Substance:
|
0/Anti-Asthmatic Agents; 0/Glucocorticoids |
| Comments/Corrections | |
Comment In:
|
Thorax. 2009 Dec;64(12):1013-4
[PMID:
19952228
]
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: A short-term comparative study of high frequency chest wall oscillation and European airway clearanc...
Next Document: Coagulation factors in the airways in moderate and severe asthma and the effect of inhaled steroids.